Cancer cells acquire distinct metabolic adaptations to survive stress associated with tumour growth and to satisfy the anabolic demands of proliferation. The tumour suppressor protein p53 (also known as TP53) influences a range of cellular metabolic processes, including glycolysis 1,2 , oxidative phosphorylation 3 , glutaminolysis 4, 5 and anti-oxidant response 6 . In contrast to its role in promoting apoptosis during DNA-damaging stress, p53 can promote cell survival during metabolic stress 7 , a function that may contribute not only to tumour suppression but also to non-cancerassociated functions of p53 8 . Here we show that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle. Transient p53-p21 (also known as CDKN1A) activation and cell-cycle arrest promoted cell survival by efficiently channelling depleted serine stores to glutathione synthesis, thus preserving cellular anti-oxidant capacity. Cells lacking p53 failed to complete the response to serine depletion, resulting in oxidative stress, reduced viability and severely impaired proliferation. The role of p53 in supporting cancer cell proliferation under serine starvation was translated to an in vivo model, indicating that serine depletion has a potential role in the treatment of p53-deficient tumours.
As p53 contributes to the survival of cells deprived of glucose 7 , we investigated whether removal of other nutrients found in normal medium induced a differential response in p53 1/1 and p53 2/2 HCT116 cells. Whereas removal of the non-essential amino acids serine and glycine impaired proliferation of p53 1/1 cells, p53 2/2 cells showed a more marked loss of proliferation ( Fig. 1a ) and substantial loss of viability ( Fig. 1b, c) . The contribution of p53 to growth and survival during serine and glycine depletion was also seen in RKO cells (Supplementary Fig. 2a -c) and primary mouse embryonic fibroblasts (MEFs; Supplementary Fig. 2d ). By removing serine or glycine individually, we established that serine depletion was the major contributor to the starvation phenotype (Fig. 1a-c) , as removal of glycine alone had no detrimental effect. Whereas serine and glycine may be inter-converted by serine hydroxymethyltransferase (SHMT), serine to glycine conversion supports proliferation via methyl-tetrahydrofolate (THF) production ( Supplementary Fig. 1 ). The reverse reaction (glycine to serine) depletes methyl-THF, which is presumably why excess glycine has been shown to inhibit proliferation 9, 10 . As expected, removal of lysine (an essential amino acid) did not cause a differential response, being equally incompatible with proliferation in p53 1/1 and p53 2/2 cells ( Supplementary Fig. 2e ).
Analysis of cell culture medium by liquid chromatography-mass spectrometry (LC-MS) revealed rapid serine consumption by p53 1/1 and p53 2/2 cells ( Fig. 1d ), whereas glycine uptake was low (Supplementary Fig. 2f ). A recent screen of NCI-60 cancer cell lines showed that elevated SHMT expression and glycine uptake were correlated with rapid proliferation 11 . Notably, all 60 lines consumed more serine than glycine, including seven lines with the shortest doubling times (,22 h), which on average consumed 7.7-fold more serine than glycine 11 . Furthermore, cells with the shortest doubling times and highest glycine uptake also consumed most of the available serine 11 , raising the possibility that these highly proliferative cells switch to glycine consumption because they have exhausted the available serine. Overall this demonstrates that cancer cells avidly consume serine, which may, through high SHMT expression, be used to generate glycine and methyl-THF.
Unlike essential amino acids, the chronic depletion of non-essential amino acids can be tolerated in vivo. Mice tolerated diets lacking serine and glycine well ( Supplementary Fig. 3a ), and LC-MS confirmed a significant drop in serum levels of serine and glycine, but not other amino acids ( Supplementary Fig. 3b ). HCT116 cells rapidly formed tumours in animals fed control diet, without a significant difference in volume between p53 1/1 and p53 2/2 tumours ( Fig. 1e ). However, animals fed matched diet lacking serine and glycine displayed significant reduction in the volume of tumours of both genotypes, and survived significantly longer before tumour size or ulceration endpoints ( Fig. 1e , f). As with our in vitro studies, serine and glycine starvation had a more dramatic effect on p53 2/2 xenografts, which had significantly reduced volume compared to p53 1/1 tumours in serine-and glycine-deprived animals ( Fig. 1e ).
Mammalian cells synthesize serine de novo by channelling the glycolytic intermediate 3-phosphoglycerate into the 'phosphorylated pathway' of serine synthesis 12 ( Supplementary Fig. 1 ). Flux through this biosynthetic pathway is controlled primarily by the demand for serine, rather than the availability of substrate 3-phosphoglycerate 13 . The serine synthesis pathway (SSP) supports anabolism by providing precursors for biosynthesis of proteins, nucleotides, creatine, porphyrins, phospholipids and glutathione, and SSP upregulation occurs in some breast cancers [14] [15] [16] . A recent study demonstrated that serine starvation activates the SSP 17 ; we found that serine starvation induced strong p53-independent upregulation of PHGDH and PSAT1, with a modest increase in PSPH ( Fig. 1g and Supplementary Fig. 4a , b). The failure of p53 2/2 cells to proliferate during serine starvation could not therefore be attributed to a deficiency in SSP enzyme expression. p53 has been shown to downregulate PGAM 18 -potentially allowing 3-phosphoglycerate to be channelled to the SSP. However, PGAM expression did not vary greatly during serine starvation (Supplementary Fig. 4a, b ). Consistent with their ability to activate the SSP, both p53 1/1 and p53 2/2 cells achieved de novo serine synthesis, as detected using [U-13 C]glucose labelling ( Fig. 1h ). However, p53 2/2 cells had lower serine levels, indicating some defect in the ability of these cells to adapt to de novo serine synthesis. We therefore sought to explore the mechanisms through which cells adapt to serine starvation.
The mTOR pathway senses amino acid availability, and whereas mTORC1 activity was lowered by serine starvation, it was maintained at very similar levels in p53 1/1 and p53 2/2 cells ( Supplementary Fig. 5 ). This demonstrated that the effect of serine starvation on mTORC1 was p53-independent and therefore unlikely to contribute to the enhanced sensitivity of p53 2/2 cells. A similar maintenance of mTORC1 activity in serine-starved cells has recently been shown, and is promoted by PKM2 expression 17 . Serine activates PKM2 19 and decreased PKM2 activity following serine starvation causes an accumulation of upstream glycolytic intermediates for diversion to the SSP 20 . To balance lower glycolysis following PKM2 inhibition, cells increase flux of pyruvate to the tricarboxylic acid (TCA) cycle, requiring cells depleted of PKM to display increased O 2 consumption to support elevated oxidative phosphorylation 20 . Both p53 1/1 and p53 2/2 cells displayed elevated phosphoenolpyruvate (PEP) levels and decreased pyruvate and lactate levels, evidence of low PKM2 activity following serine starvation ( Fig. 2a ). The importance of oxidative phosphorylation during serine starvation was demonstrated by treatment with the mitochondrial ATP synthase inhibitor Oligomycin (Fig. 2b) , which completely inhibited the growth of serine-deprived p53 1/1 cells. As p53 supports oxidative phosphorylation 3,21,22 , we considered the possibility that p53 2/2 cells would be unable to upregulate oxidative phosphorylation in response to serine starvation.
As expected, p53 2/2 cells showed lower O 2 consumption than p53 1/1 cells under fed conditions. Surprisingly, p53 2/2 cells responded to serine starvation with increased O 2 consumption, whereas p53 1/1 cells showed lower O 2 consumption ( Fig. 2c ). Closer analysis of metabolic flux into the TCA cycle revealed that whereas both p53 1/1 and p53 2/2 cells showed an increase in glycolytic TCA cycle flux in the immediate response to serine starvation, this response was reversed over time in p53 1/1 cells, but sustained in the p53 2/2 cells ( Fig. 2d, e ). This correlated with the changes in O 2 consumption observed during serine starvation, indicating that the initial response of p53 1/1 and p53 2/2 to serine depletion is similar, but p53 2/2 cells sustain a metabolic profile indicative of low PKM2 activity, including elevated O 2 consumption.
We predicted that the disruption to glycolysis in the immediate response to serine starvation would impede ATP production, indeed ATP levels dropped in both p53 1/1 and p53 2/2 cells ( Fig. 2f ). We considered that as glycolytic flux to pyruvate is lowered by serine starvation, increasing pyruvate levels (by adding exogenous pyruvate) would potentially alleviate the ATP shortage by further enhancing flux to the TCA cycle. We observed a significant recovery in proliferation of p53 2/2 cells after adding pyruvate ( Fig. 2g ). LC-MS analysis of Peak area
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serine-starved p53 2/2 cells fed unlabelled pyruvate (in the presence of [U-13 C]glucose) confirmed increased TCA cycle flux ( Supplementary  Fig. 6 ). However, this enhanced TCA cycle flux was not sufficient to fully restore proliferation (Fig. 2g ). Importantly, although it has recently been shown that serine can be synthesised from pyruvate (reviewed in ref. 30) , we detected only labelled serine in the cells fed unlabelled pyruvate ( Supplementary Fig. 6 ), demonstrating that the serine in these cells was derived from glucose. Serine contributes to the synthesis of purines via glycine, which is incorporated into GMP and AMP via inosine monophosphate (IMP). Serine starvation resulted in lower GMP and AMP levels in p53 1/1 and p53 2/2 cells (Fig. 3a) . Previous studies show that GMP depletion can activate p53-dependent G1 arrest 23, 24 . Consistently, we found that serine starvation led to a small elevation in p53 expression, accompanied by more marked, but transient, elevation of the p53 target protein p21 (Fig. 3b ). Treatment of p53 1/1 cells with low doses of mycophenolic acid (an inhibitor of GMP synthesis) replicated this subtle p53-p21 response ( Supplementary Fig. 7a, b ). Recruitment of p53 to the p21 promoter during serine starvation was confirmed by chromatin-immunoprecipitation ( Fig. 3c ). As only a modest increase in p53 expression was observed, we speculate that p53 was activated via post-translational modification, rather than MDM2 inhibition. Although our data are consistent with p53 activation in response to nucleotide depletion, activation of AMPK ( Supplementary Fig. 7c ) due to lower ATP levels could also contribute to the p53 response 7 .
As expected following p53 activation, p53 1/1 cells starved of serine and glycine initially showed an accumulation of cells in G1 and reduced S-phase, correlating with the increased expression of p21 (Fig. 3d ). By 48 h, these cells resumed a normal cell cycle. By comparison, p53 2/2 cells failed to establish a strong G1 arrest, showing a more gradual decrease in S-phase (corresponding to an increase in sub-G1 cells, Fig. 1b ) and did not recover normal cell cycle (Fig. 3d) . Because p21 is a major mediator of p53-induced G1 arrest 25 , we examined the effect of p21 loss in p53 1/1 cells. p21 2/2 (CDNK1A 2/2 ) cells showed a similar cell-cycle response as p53 2/2 cells (Fig. 3d) , indicating that induction of p21 may be critical for adaptation to serine starvation. Indeed, p53 1/1 cells depleted of p21 by siRNA were unable to increase in number without serine (similar to p53 2/2 cells, Fig. 3e ), a response even more notable in cells genetically deleted of p21 (Fig. 3f) .
We next considered whether p53 1/1 and p53 2/2 cells use the low levels of intracellular serine available under conditions of starvation differently. Specifically, we analysed the balance between purinenucleotide and glutathione synthesis, both of which require serine/ glycine. LC-MS showed that after 24 h, p53 2/2 cells retained flux of de novo serine/glycine into IMP (M17), but this was inhibited in p53 1/1 cells (Fig. 4a ). Re-feeding serine-starved cells with [U-13 C, 15 N]L-serine confirmed sustained serine flux into IMP, GMP and AMP in p53 2/2 cells ( Supplementary Fig. 8a ). However, in serinestarved p53 1/1 cells, flux of the replenished labelled serine to nucleotides was blocked, despite plentiful intracellular serine. This demonstrated that a feature of p53-p21-induced cell-cycle arrest in response to serine starvation is inhibition of nucleotide synthesis, a known function of p21 26, 27 . Reduced glutathione (GSH) is the principal cellular anti-oxidant, and we found that levels of GSH dropped significantly in p53 1/1 and p53 2/2 serine-starved cells (Fig. 4b) . However, in contrast to nucleotides, p53 1/1 cells maintained and, over time, enhanced flux to GSH synthesis during starvation. Notably, this maintenance of flux to glutathione was not seen in p53 2/2 and p21 2/2 cells ( Fig. 4b and Supplementary Fig. 8b ). Consequently, total GSH levels showed recovery in p53 1/1 but not p53 2/2 or p21 2/2 cells ( Fig. 4c and Supplementary Fig. 8c ).
The failure of p53 2/2 cells to recover GSH levels combined with their elevated oxygen consumption suggested that these cells would accumulate increased intracellular reactive oxygen species (ROS) levels. p53 has well-established anti-oxidant functions 1, 6 , but hydrogen peroxide treatment demonstrated that p53 2/2 cells were only slightly more susceptible than p53 1/1 to oxidative stress under normal conditions ( Fig. 4d) . Although serine and glycine starvation increased the sensitivity of both genotypes to peroxide treatment, this effect was more marked in p53 2/2 cells (Fig. 4d) , and rescued by adding GSH (Fig. 4e) . Staining with an oxidation-activated fluorescent dye confirmed increased intracellular ROS in p53 2/2 cells during serine starvation ( Fig. 4f and Supplementary Fig. 9a ). To assess the importance of ROS in limiting proliferation, we tested the effect exogenous GSH or N-acetyl cysteine. Whereas anti-oxidant treatment alone modestly improved proliferation of serine-starved p53 2/2 cells, either of the ROS-limiting treatments almost completely rescued the proliferation of serine-starved p53 2/2 cells in combination with pyruvate ( Fig. 4g ). We confirmed that the exogenous GSH did not lead to accumulation of intracellular glycine or serine, demonstrating that rescue was achieved by increasing the intracellular GSH pool ( Supplementary  Fig. 9b ). Adding GSH to serine-starved p53 1/1 cells did not greatly enhance proliferation, supporting the theory that p53 1/1 cells are able to maintain GSH pools independently ( Supplementary Fig. 9c ). and activation of a transient p21-dependent G1 arrest. a, LC-MS was used to quantify total relative amounts of intracellular purine nucleotides GMP and AMP in serine and glycine fed (Com) and starved (2SG) HCT116 cells (averages of triplicate wells). b, p53 and p21 protein expression was quantified in p53 1/1 HCT116 cells via western blot and detection with infraredconjugated secondary antibodies (n 5 3). CDK4 expression was used as a control for normalisation. c, Chromatin-immunoprecipitation (ChIP) was performed for p53 with quantitative PCR for two p53-response elements (22350 bp and 21450 bp) and the transcription initiation region (150 bp) of the p21 promoter (n 5 3). HU, hydroxyurea. d, BrdU labelling and PI staining followed by flow cytometry were used to assess cell cycle (n 5 3). e, p21 was transiently knocked down in p53 1/1 HCT116 cells using short interfering RNA (siRNA, averages of triplicate wells). f, p21 2/2 HCT116 cells (retaining wildtype p53) were grown in medium with or without serine and glycine (averages of triplicate wells). All error bars are s.e.m.
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Our data therefore show that the sensitivity of p53 2/2 cells to serine depletion is due to a combination of impaired glycolysis and elevated ROS. Whereas the initial response of cells with or without p53 to serine depletion was similar, p53 1/1 cells underwent p21-dependent G1 arrest, allowing the limited levels of de novo serine to be channelled to GSH production to counter oxidative stress. Depletion of p21 (while retaining p53) caused severe sensitivity to serine depletion (Fig. 3e, f) , indicating that activation of other arms of the p53 response may contribute to the death of these cells. Our data also demonstrate that the ability of p53-deficient cells to engage higher rates of oxidative phosphorylation is not entirely defective, but that oxidative phosphorylation in these cells is probably limited by a requirement to prevent ROS generation. This observation ties in with the suggestion that cancer cells adopt aerobic glycolysis (the Warburg effect) to avoid generation of metabolic ROS 28 . It has recently been shown that increased ROS levels inhibit PKM2 29 , providing an explanation for why p53 2/2 cells show evidence of sustained PKM2 inhibition during serine starvation.
In conclusion, our study underlines the importance of p53 in coordinating metabolic remodelling in response to metabolic stress. We demonstrate that serine uptake supports the Warburg effect, indicating that many cancer cells may show some sensitivity to serine depletion, particularly those lacking p53. However, it is likely that other genetic alterations (such as PHGDH amplification [14] [15] [16] ) may circumvent serine-dependence in other cancer cells. Taken together, our work suggests the therapeutic utility of serine depletion-either by removal from the diet, enzymatic depletion in vivo, or other means-is worthy of further investigation.
METHODS SUMMARY
HCT116 p53 1/1 /p21 1/1 (parental), p53 2/2 (1ex) (deletion of p53 exon 2), p53 2/2 (3ex) (deletion of p53 exons 2, 3 and 4), p21 2/2 and RKO p53 1/1 and p53 2/2 cells were a gift of B. Vogelstein. Litter-matched p53 1/1 and p53 2/2 MEFs were prepared from embryonic day 14.5 (E14.5) embryos derived from mating p53 1/2 mice. For starvation, cells were initially grown in DMEM (which contains serine 0.4 mM and glycine 0.4 mM); complete medium (Com) was formulated by supplementing MEM with additional nutrients to closely match the nutrient content of DMEM. Serine-and glycine-deficient medium (2SG) was formulated in the same way as complete medium, without addition of serine and glycine. Bilateral subcutaneous injections of HCT116 cells were carried out on CD-1-Foxn1 nu female mice (Charles River); p53 1/1 on right flank and p53 2/2 (1ex) on the left. Following injection, mice were placed either on control diet (containing serine and glycine as part of the amino-acid mix) or diet deficient in serine and glycine (TestDiet, International Product Supplies). The diets had equal calorific value and equal total amino acid content. Animals were housed in sterile IVC cages, monitored thrice weekly and killed humanely when tumours reached clinical endpoint of predetermined size (volume 5 (length 3 width 2 )/2) or ulceration. All animal work was undertaken in line with the UK Animals (Scientific Procedures) Act of 1986 and the EU directive 2010. Cell-cycle analysis was performed by labelling with 5-bromo-29-deoxyuridine (BrdU) and propidium iodide (PI) staining followed by flow cytometry. Oxygen consumption rates were measured with an XF-24 extracellular flux analyser (SeaHorse Bioscience). ROS levels were detected with CellROX deep red reagent (Invitrogen). ATP levels were assayed with a luciferase-based kit. The relative quantities of intracellular metabolites after labelling with [U-13 C]glucose or [U-13 C, 15 N]L-serine were analysed by LC-MS and plotted as the peak area for each metabolite. LETTER RESEARCH
